National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
70.88
-1.03 (-1.43%)
Sep 4, 2026, 4:00 PM EDT - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, National Health Investors stock has a consensus rating of "Buy" and an average price target of $82.13. The average 1-year stock price forecast is 15.87% higher than the current stock price, while the lowest is $73 (+2.99%) and the highest is $90 (+26.98%).
Price Target: $82.13 (+15.87%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $81 → $80 | Buy | Maintains | $81 → $80 | +12.87% | Sep 2, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $79 → $78 | Hold | Reiterates | $79 → $78 | +10.05% | Sep 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $91 → $86 | Buy | Maintains | $91 → $86 | +21.33% | Aug 24, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +26.98% | Aug 14, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $85 → $80 | Hold | Maintains | $85 → $80 | +12.87% | Jun 25, 2026 |
Financial Forecast
Revenue This Year
456.49M
from 379.29M
Increased by 20.35%
Revenue Next Year
477.01M
from 456.49M
Increased by 4.49%
EPS This Year
14.55
from 2.93
Increased by 396.65%
EPS Next Year
3.25
from 14.55
Decreased by -77.69%
EPS based on non-GAAP adjusted numbers.